ran frenkel  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in ran frenkel chief development operations officer at karyopharm therapeutics inc view full profile are you ran frenkel claim your profile   sign up for equilar atlas and view ran frenkels full profile with equilar atlas you can identify corporate executives in ran frenkels network and community follow changes in ran frenkels employment and moneyinmotion connect with ran frenkel through your network of contacts ran frenkels executive work history current chief development operations officer karyopharm therapeutics inc past to view ran frenkels complete executive work history sign up now age      sign up for equilar atlas and view ran frenkels full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like ran frenkel more specifically youll be able to identify corporate executives in ran frenkels network and community follow changes in ran frenkels employment and moneyinmotion connect with ran frenkel through your network of conections view full profile   search for over  executive profiles bio example ran frenkel ran frenkels connections  sign up now to view ran frenkels  connections » mikael dolsten president worldwide research and development pfizer inc j scott garland chief commercial officer and senior vice president relypsa inc justin a renz advisor karyopharm therapeutics inc sharon shacham president and chief scientific officer karyopharm therapeutics inc deepika r pakianathan former board member alder biopharmaceuticals inc christopher b primiano senior vice president corporate development general counsel and secretary karyopharm therapeutics inc michael g kauffman dir and chief executive officer karyopharm therapeutics inc kenneth e weg board member karyopharm therapeutics inc barry e greene president alnylam pharmaceuticals inc garen g bohlin former chief operating officer sirtris pharmaceuticals inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith carl g annessa evp and coo hornbeck offshore services inc elon r musk ceo and chairman tesla michael c montgomery board member nmi holdings inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login ï¿½  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   ran frenkel  chief executive officer at pfc pharma focus israel ltd news home advertising board and executive moves energy health care hedge funds m  a private equity technology you have    free profiles   left this month    start your free trial ➤ hey we noticed youre a relsci pro subscriber would you like to view the page there view on relsci pro ➤ email linkedin facebook google tweet reddit permalink ran frenkel chief executive officer at pfc pharma focus israel ltd overview in the news relationships paths education career history public holdings ran frenkel chief executive officer at pfc pharma focus israel ltd overview age  born  notable companies pfc pharma focus israel ltd number of relationships this person is connected to  people in the news see more business wire april   karyopharm and medidata expand clinical trial partnership boston business journal november   karyopharm settles into new home gears up for biggest drug trial yet business wire july   clinipace worldwide announces strategic partnership with nordicbased medfiles relationships see details mordechai peer chief technology officer at pd solutions ltd ofer baram chief executive officer at pd solutions ltd michael g kauffman cofounder at karyopharm therapeutics inc sharon shacham cofounder at karyopharm therapeutics inc christopher b primiano senior vice president operations business development general counsel  secretary at karyopharm therapeutics inc brian austad vice president head of pharmaceutical sciences at karyopharm therapeutics inc erkan baloglu head medicinal chemistry at karyopharm therapeutics inc ori kalid acting head of discovery  consultant at karyopharm therapeutics inc yosef landesman senior director biology at karyopharm therapeutics inc mike todisco chief financial  accounting officer at karyopharm therapeutics inc see  more listings with relsci professional start my free trial ➤ see  more paths to ran frenkel ran frenkel you connections via relationship science ran frenkel sync your contacts to see how you can connect with ran frenkel start my free trial ➤ see more educational background   class of   the hebrew university of jerusalem the hebrew university of jerusalem is israels second oldest university established in   years before the state of israel the hebrew university has three campuses in jerusalem and one in rehovot the worlds largest jewish studies library is located on its edmond j safra givat ram campus career history chief development operations officer   current karyopharm therapeutics inc karyopharm therapeutics inc is a clinicalstage pharmaceutical company which discovers develops and commercializes drugs to treat cancer and other major diseases the company intends to initiate a pivotal randomized phase  study of selinexor in combination with bortezomib velcade and lowdose dexamethasone boston in patients with multiple myeloma karyopharm therapeutics was founded by joseph araujo ronald a depinho pamela a silver giulio draetta michael g kauffman and sharon shacham on december   and is headquartered in newton ma chief executive officer current pfc pharma focus israel ltd vice presidentbusiness development current pd solutions ltd pd solutions ltd develops an automated drug monitoring system its products include clinicaid and slimpack the company was founded by ofer baram and mordechai peer in  and is headquartered in tel aviv israel managing directoremea prior clinipace inc clinipace inc provides digital contract research solutions it operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies clinical development and postapproval research its service areas encompass clinical monitoring data management medical affairs and writing patient recruitment study feasibility and site selection and management the company was founded by ronald g marks christopher k porter and jeff l williams in  and is headquartered in morrisville nc managing director prior actelion pharmaceuticals us inc public holdings restricted data only for relsci professional users start my free trial ➤ see more other affiliations ran frenkel is affiliated with karyopharm therapeutics inc pfc pharma focus israel ltd pd solutions ltd clinipace inc actelion pharmaceuticals us inc youve reached your  free profiles limit this month upgrade to relsci pro today to enjoy unlimited article views and much more start my free trial ➤ still not convinced check out our full listing of features here are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ product liability attorneys  dallas lawyers  frenkel firm call  for a free consultation get help nowcall for a free consultation home practice areasvehicle accidents medical malpractice drug litigation injuries on the job other attorneysmark d frenkel scott bennet frenkel gene burkett dave adest jason boorstein joshua cohen andrew gross carlos a fernandez aaron spahr contact us faq blog menu other dog bites child injury construction industrial product liability personal injury lawyers fighting to hold negligent parties responsiblegetting you the compensation you deserveproduct liability lawsuits can be expensive and laborintensive the product liability lawyers at frenkel  frenkel work with victims who have suffered injury or lost loved ones as a result of dangerous or defective products injuries to children have a lifelong effect on their caregivers and loved ones frenkel  frenkel is also experienced in personal injury law our dallas texas attorneys work hard for every client but especially take to heart cases where children are hurt or lose their lives nyc insurance company  insurance agency  frenkel  year history of independence home careers news contact us request a quote about us executive team divisions programs partners how frenkel does it best frenkel  company was established in  by emil frenkel his sons leo and george developed their insurance brokerage business over several decades by calling door to door on prospective clients in new york our business strategy has evolved since then but our clientcentric platform continues to serve us well in today’s competitive marketplace we now maintain offices across the united states in new york jersey city boston philadelphia and california we employ insurance experts who are well versed in global insurance trends and also maintain strong personal relationships within these industry segments casualty employee benefits environmental financial marine personal lines property and surety our departmental model is based on frenkel clients’ demands for direct access to the specific team professional that can answer their questions and provide the services they need—in an expedient manner each frenkel division works directly with our inhouse claims and other support services divisions to seamlessly guide our clients through the entire process of buying insurance at the best rates and providing satisfactory resolution of insurance claims—whether they are personal lines clients small business owners corporate risk management teams or medical professionals this personal attention results in our effectiveness across the board as we manage both personal and business insurance programs for a wide range of executives—a favorable testament to frenkel’s client service platform frenkel’s reinvestment in our workforce results in our firm’s high ranking among insurance business magazine’s “ largest us brokers” we stand apart from our competition as an independent insurance broker with annual premium distribution of over one billion dollars this premium distribution is placed with global national and regional insurance carriers including our expansive employee benefits operation frenkel’s service platform involves investing time and money in diverse community oriented charities of interest to our clients as well including the insurance industry charitable foundation habitat for humanity and care for the homeless about us executive team divisions programs partners home careers news contact us request a quote clinipace worldwide’s ran frenkel promoted to managing director emea skip to main content advertisement advertisement home topicscardiovascular diabetes home healthcare implantables medical diagnostics neurology oncology orthopedics pain management prosthetics regenerative medicine surgical wearables watchmdt live search socialfacebook twitter youtube guidescompanies products learn digital login register subscribe channelspdd ced ecn wdd ww advertisement clinipace worldwide’s ran frenkel promoted to managing director emea thu   am comments by the associated press morrisville ncbusiness wiredec  clinipace worldwide a global digital contract research organization dcro today announced company executive ran frenkel rph vice president international business development will take on additional responsibility as the managing director emea country managers in the region will report directly to frenkel in his new role frenkel joined the clinipace worldwide team in may  through the company’s acquisition of swissbased pfc pharma focus pfc he has served the company for over seven years helping to establish the israel office and is now poised to lead emea operations from the european headquarters in zurich “ran has consistently demonstrated that he understands and supports our corporate vision of driving innovation in clinical research through a technologyamplified service platform” said jeff williams ceo clinipace worldwide “ran is committed to extending our unique approach to service delivery throughout emea and i’m confident he will continue to lead our growth in the region” original pfc founders kurt pfister phd ceo european operations and kathryn voegeli phd coo european operations are stepping down from daytoday management roles they will remain with clinipace worldwide through  in an advisory capacity and will remain on the board of directors of clinipace ag the company’s european entity “clinipace is proud of the leadership demonstrated by both kurt and kathryn in growing the company’s presence and foothold in emea” said williams “they helped build a talented team of experts and as a combined company for the past two years our common goals have been easily achieved” see related clinipace worldwide’s ran frenkel elected to iisra board of directors clinipace worldwide celebrates  years of service in europe clinipace worldwide acquires switzerlandbased pfc pharma focus ltd about clinipace worldwide as a global fullservice digital contract research organization dcro we have pioneered an innovative technologyamplified cro service model to serve the unique needs of venturebacked midtier and strategic pharmaceutical biotechnology and medical device firms powered by tempo™ our proprietary eclinical platform our team of experts brings extensive therapeutic knowledge and insight into assisting life science firms in developing and executing regulatory strategies clinical development and postapproval research to ensure a successful drug and medical device development program we have managed over  global clinical research strategic product development regulatory and gxpcmcqa projects in therapeutic areas such as cardiovascular  metabolic diseases central nervous system dermatology gastroenterology immunology infectious diseases nephrology oncology respiratory rheumatology and vaccines and other cell and tissue based therapies clinipace worldwide is headquartered in research triangle park north carolina with offices in irvine ca boulder co overland park ks zurich ch munich de high wycombe uk telaviv il sao paulo br buenos aires ar trivandrum kerala in and new delhi in for more information visit our website at wwwclinipacecom contact for clinipace worldwide molly thompson  mthompsoncrossroadsprcom keyword united states europe north america north carolina middle east israel industry keyword health biotechnology clinical trials pharmaceutical research science source clinipace worldwide copyright business wire  pub   amdisc   am httpwwwbusinesswirecomnewshome55 advertisement advertisement view the discussion thread advertisement connect with medical design technology facebook twitter youtube resources about us advertising info contact us contributor guidelines digital editions directory faqs privacy policy product announcement form subscriptions terms  conditions topics cardiovascular diabetes home healthcare implantables medical diagnostics neurology oncology orthopedics pain management prosthetics regenerative medicine surgical wearables advantage business media  copyright  advantage business media ran frenkel  karyopharm therapeutics careers contact ran frenkel management team ran frenkel rph chief development operations officer mr frenkel was appointed executive vice president worldwide development operations of karyopharm in october  mr frenkel is responsible for managing the subsidiary karyopharm europe gmbh which will provide the corporate structure necessary to support karyopharm’s expanded clinical and regulatory activities in europe in addition frenkel is responsible for the corporate global development operations across the entire portfolio in this capacity frenkel is managing the clinical departments including clinical operations product leadership quality regulatory affairs medical writing medical  scientific affairs and biology mr frenkel has more than  years of experience in the international biopharmaceutical industry encompassing clinical regulatory business development and commercial operations activities prior to joining karyopharm europe gmbh mr frenkel held a number of senior management roles in europe israel and the united states most recently as managing director emea for clinipace worldwide an international clinical research organization where he had responsibility for the overall management of the organization in europe the middle east and africa prior to joining clinipace worldwide mr frenkel established and managed the israeli office of pfc pharma focus ag which was acquired by clinipace in  and he held the position of managing director at actelion pharmaceuticals with responsibility for all science and business affairs of the company in israel meet christopher primiano senior vice president operations business development general counsel  secretary read next bio « previous bio overview mission management team board of directors scientific advisory board usakaryopharm therapeutics corporate headquarters  wells ave nd floor newton ma 5   main phone number usa  germanykaryopharm therapeutics sitz der gesellschaft karyopharm europe gmbh franziskabilekweg   münchen germany   tel    – 5   fax    – 5   general contact information about sine™ technology drug candidates investors publications contact careers   karyopharm therapeutics terms of use privacy policy clinipace’s ran frenkel promoted to managing director emea   contact us twitter linkedin rss twitter linkedin rss select page clinipace worldwide’s ran frenkel promoted to managing director emea by clinipace  dec    news   comments morrisville nc business wire december   – clinipace worldwide a global digital contract research organization dcro today announced company executive ran frenkel rph vice president international business development will take on additional responsibility as the managing director emea  country managers in the region will report directly to frenkel in his new role frenkel joined the clinipace worldwide team in may  through the company’s acquisition of swissbased pfc pharma focus pfc  he has served the company for over seven years helping to establish the israel office and is now poised to lead emea operations from the european headquarters in zurich “ran has consistently demonstrated that he understands and supports our corporate vision of driving innovation in clinical research through a technologyamplified service platform” said jeff williams ceo clinipace worldwide  “ran is committed to extending our unique approach to service delivery throughout emea and i’m confident he will continue to lead our growth in the region” original pfc founders kurt pfister phd ceo european operations and kathryn voegeli phd coo european operations are stepping down from daytoday management roles  they will remain with clinipace worldwide through  in an advisory capacity and will remain on the board of directors of clinipace ag the company’s european entity “clinipace is proud of the leadership demonstrated by both kurt and kathryn in growing the company’s presence and foothold in emea” said williams  “they helped build a talented team of experts and as a combined company for the past two years our common goals have been easily achieved” see related clinipace worldwide’s ran frenkel elected to iisra board of directors clinipace worldwide celebrates  years of service in europe clinipace worldwide acquires switzerlandbased pfc pharma focus ltd about clinipace worldwide as a global fullservice digital contract research organization dcro we have pioneered an innovative technologyamplified cro service model to serve the unique needs of venturebacked midtier and strategic pharmaceutical biotechnology and medical device firms  powered by tempo™ our proprietary eclinical platform our team of experts brings extensive therapeutic knowledge and insight into assisting life science firms in developing and executing regulatory strategies clinical development and postapproval research to ensure a successful drug and medical device development program  we have managed over  global clinical research strategic product development regulatory and gxpcmcqa projects in therapeutic areas such as cardiovascular  metabolic diseases central nervous system dermatology gastroenterology immunology infectious diseases nephrology oncology respiratory rheumatology and vaccines and other cell and tissue based therapies  clinipace worldwide is headquartered in research triangle park north carolina with offices in irvine ca boulder co overland park ks zurich ch munich de high wycombe uk telaviv il sao paulo br buenos aires ar trivandrum kerala in and new delhi in  for more information visit our website at wwwclinipacecom leave a reply cancel reply posts by topicposts by topic select category blog cardiometabolic clinical manufacturing clinical research clinical trials company announcement digital cro drug development infectious disease medical device development news oncology other patient recruitmentenrollment registry regulatory development risk based monitoring site selection study startup women’s health operational assets clinical manufacturing risk based monitoring study startup digital cro drug development medical device patient recruitment therapeutic assets oncology infectious disease cardiovascular central nervous system obgyn  urology search search for ran frenkel  karyopharm therapeutics insider transactions  tipranks go prologin  sign up follow✓get real time transactionsinsider detailsran frenkelkaryopharm therapeutics kptichief dev operations officerranked  out of  insiders on tipranksran frenkels performanceprofitable transactions out of  profitable transactionsaverage returnaverage return per transactioneach transaction is measured over a  year months month period and compared to no benchmarksp 5sectorhow are insiders ranked insider holdings  karyopharm therapeutics kptiksee the top stocks by insiders  insider roleskaryopharm therapeutics kpti chief dev operations officersee the top 5 corporate insiders  most profitable insider tradestock karyopharm therapeutics kptitransaction type informative selldates nov 5   todaygain see the latest stocks traded by insiders  ran frenkels trading historybased on form  follow✓get real time transactionscompany nameinsider positionholding valuelast transactionlast transaction amountlast transaction datekptikaryopharm therapeuticschief dev operations officer5informative sell555nov 5 success rate on stock out of  profitable transactions on kptiaverage profit on stockaverage return per transaction on kpti  track record showingall transactionsinformative transactionsdatetransactionamountno of sharesprice per shareprofitform  nov 5  informative sell k    nov   uninformative buy  5  na apr  5 informative buy 5k    see all insider trading from today you may also likemeet our smart portfolio see what top analysts say about your stocksget a breakdown of the different strategies based on detected insider trading activityfind the best performing analyst in each sector follow them so you never miss a recommendationrelated linkshow can i benefit from insider trading see the top 5 corporate insiders go to hot stocks by insiders find which stocks insiders traded today become a tipranks memberget the best investing tips  hacks straight to your emailfree membershipsubmitinsider trading daily newsletterprofessional daytrading strategy based on predictive insider transactionsannual return learn more powered by